M2-macrophages and Mesenchymal Cells therapy(Peaches Biotech)
- Generic Name
- M2-macrophages and Mesenchymal Cells therapy(Peaches Biotech)
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Prevention of COVID-19-Associated Cytokine Storm
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- PEACHES BIOTECH
- Target Recruit Count
- 50
- Registration Number
- NCT06684379
- Locations
- 🇪🇸
Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath